Bill H.574, introduced by Representative Harple, aims to enhance the safety of children in child care facilities by allowing providers to maintain a stock supply of epinephrine and designate trained personnel to administer it in emergencies. The bill introduces new legal language that defines key terms such as "designated personnel," "epinephrine," and "health care professional," and outlines the responsibilities of health care professionals in prescribing epinephrine. It also establishes protocols for recognizing and responding to life-threatening allergic reactions, including the administration of epinephrine and post-emergency care.

Additionally, the bill provides immunity from civil or criminal liability for designated personnel, child care providers, and health care professionals involved in the administration of epinephrine, unless intentional misconduct occurs. The Division, in consultation with the Department of Health, is tasked with adopting rules to manage children with life-threatening allergies, which include developing individualized allergy management plans and ensuring proper training for child care providers. The provisions of this act are set to take effect on July 1, 2026.